SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Stay informed with null’s coverage and analysis for Fortune.
Page 48 of 100
Health
Pushback grows against fourth COVID vaccine doses, with experts urging caution over expanding booster campaigns
By
David Meyer
Newsletters
As Germany’s COVID vaccine mandate is delayed, beware anyone who says the issue has easy answers
By
David Meyer
International
Outside the U.S., the COVID school debate is (mostly) settled—even as Omicron surges
By
Grady McGregor
and
David Meyer
Tech
France cracks down on dark patterns, fining Google and Facebook nearly $240 million for manipulative cookie tricks
By
David Meyer
Newsletters
Crypto miners face an unfriendly world
By
David Meyer
and
Alan Murray
Newsletters
There’s strong disagreement about how 2022 will play out in the markets
By
David Meyer
Tech
How improvements to AT&T and Verizon’s 5G networks sparked a war with the aviation sector
By
David Meyer
Newsletters
Blackbaud’s EVERFI purchase highlights corporate demand for addressing environmental and social goals
By
David Meyer
and
Alan Murray
Newsletters
2022 will be a year of continuing transformation
By
David Meyer
and
Alan Murray
Health
Moderna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
By
David Meyer
Health
Europe too has a COVID testing crisis, and a Christmas Omicron wave is making it worse
By
David Meyer
,
Vivienne Walt
, and others
Health
3 studies now suggest Omicron is milder than the Delta COVID variant
By
David Meyer
Health
Israel to give fourth COVID vaccine doses to combat Omicron, despite lack of data on second boosters
By
David Meyer
Finance
Turkey’s lira leaps by more than 40% in a day after President Erdogan unveils unorthodox plan to lure Turks away from dollars
By
David Meyer
International
World Economic Forum postpones January summit as the rise of Omicron stymies Davos yet again
By
David Meyer